Annual D&A
$219.30 K
-$27.80 K-11.25%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual depreciation & amortization is currently $219.30 thousand, with the most recent change of -$27.80 thousand (-11.25%) on 31 December 2022. During the last 3 years, it has risen by +$12.30 thousand (+5.94%).ZYNE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$65.70 K
+$14.10 K+27.33%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly depreciation & amortization is currently $65.70 thousand, with the most recent change of +$14.10 thousand (+27.33%) on 30 June 2023.ZYNE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$221.90 K
+$11.70 K+5.57%
30 June 2023
Summary:
Zynerba Pharmaceuticals TTM depreciation & amortization is currently $221.90 thousand, with the most recent change of +$11.70 thousand (+5.57%) on 30 June 2023.ZYNE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +5.9% | +6.1% | -9.5% |
| 5 y5 years | +120.2% | +82.5% | +78.1% |
ZYNE Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -11.3% | at high | -10.2% |
Zynerba Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $65.70 K(+27.3%) | $221.90 K(+5.6%) |
| Mar 2023 | - | $51.60 K(-3.4%) | $210.20 K(-4.1%) |
| Dec 2022 | $219.30 K(-11.3%) | $53.40 K(+4.3%) | $219.30 K(-3.7%) |
| Sept 2022 | - | $51.20 K(-5.2%) | $227.80 K(-4.5%) |
| June 2022 | - | $54.00 K(-11.0%) | $238.50 K(-3.2%) |
| Mar 2022 | - | $60.70 K(-1.9%) | $246.40 K(-0.3%) |
| Dec 2021 | $247.10 K(+19.4%) | $61.90 K(0.0%) | $247.20 K(+0.9%) |
| Sept 2021 | - | $61.90 K(0.0%) | $245.10 K(+1.7%) |
| June 2021 | - | $61.90 K(+0.7%) | $241.00 K(+6.0%) |
| Mar 2021 | - | $61.50 K(+2.8%) | $227.30 K(+9.8%) |
| Dec 2020 | $207.00 K(+54.6%) | $59.80 K(+3.5%) | $207.00 K(+13.2%) |
| Sept 2020 | - | $57.80 K(+19.9%) | $182.90 K(+13.5%) |
| June 2020 | - | $48.20 K(+17.0%) | $161.10 K(+10.5%) |
| Mar 2020 | - | $41.20 K(+15.4%) | $145.80 K(+8.9%) |
| Dec 2019 | $133.90 K(+34.4%) | $35.70 K(-0.8%) | $133.90 K(+7.5%) |
| Sept 2019 | - | $36.00 K(+9.4%) | $124.60 K(+9.7%) |
| June 2019 | - | $32.90 K(+12.3%) | $113.60 K(+11.0%) |
| Mar 2019 | - | $29.30 K(+11.0%) | $102.30 K(+2.7%) |
| Dec 2018 | $99.60 K | $26.40 K(+5.6%) | $99.60 K(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $25.00 K(+15.7%) | $99.00 K(+0.2%) |
| June 2018 | - | $21.60 K(-18.8%) | $98.80 K(-1.6%) |
| Mar 2018 | - | $26.60 K(+3.1%) | $100.40 K(+6.6%) |
| Dec 2017 | $94.20 K(+25.1%) | $25.80 K(+4.0%) | $94.20 K(+4.2%) |
| Sept 2017 | - | $24.80 K(+6.9%) | $90.40 K(-1.1%) |
| June 2017 | - | $23.20 K(+13.7%) | $91.40 K(+11.3%) |
| Mar 2017 | - | $20.40 K(-7.3%) | $82.10 K(+9.0%) |
| Dec 2016 | $75.30 K(+189.6%) | $22.00 K(-14.7%) | $75.30 K(+13.1%) |
| Sept 2016 | - | $25.80 K(+85.6%) | $66.60 K(+35.9%) |
| June 2016 | - | $13.90 K(+2.2%) | $49.00 K(+28.3%) |
| Mar 2016 | - | $13.60 K(+2.3%) | $38.20 K(+46.9%) |
| Dec 2015 | $26.00 K(-4.1%) | $13.30 K(+62.2%) | $26.00 K(+83.1%) |
| Sept 2015 | - | $8200.00(+164.5%) | $14.20 K(+10.1%) |
| June 2015 | - | $3100.00(+121.4%) | $12.90 K(-31.7%) |
| Mar 2015 | - | $1400.00(-6.7%) | $18.90 K(-30.3%) |
| Dec 2014 | $27.10 K(-45.1%) | $1500.00(-78.3%) | $27.10 K(+5.9%) |
| Sept 2014 | - | $6900.00(-24.2%) | $25.60 K(+36.9%) |
| June 2014 | - | $9100.00(-5.2%) | $18.70 K(+94.8%) |
| Mar 2014 | - | $9600.00 | $9600.00 |
| Dec 2013 | $49.40 K | - | - |
FAQ
- What is Zynerba Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ZYNE is $219.30 K
What is the all time high annual D&A for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual depreciation & amortization is $247.10 K
What is Zynerba Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ZYNE is $65.70 K
What is the all time high quarterly D&A for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly depreciation & amortization is $65.70 K
What is Zynerba Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ZYNE is $221.90 K
What is the all time high TTM D&A for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high TTM depreciation & amortization is $247.20 K